Revealed: Terrifying side effects of Champix, from seizures to suicidal thoughts - as NHS relaunches controversial stop smoking drug
A 'game-changer' anti-smoking pill set to be rolled out on the NHS has been linked to more than 25,000 reports of side ...
Is Pfizer Inc. (PFE) Among The Top Dividend Contenders Right Now?
Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders. Dividend stocks have long been favored by investors for the income ...
AOL10h
The Oncology Bet Is Already Paying Off For Pfizer
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in ...
spectator.com.au16h
Pfizer’s crimes against humanity, with Naomi Wolf
Naomi’s most recent, and perhaps most important, contribution to the public debate has been editing the now released ...
Pfizer Sues Sandoz to Block Copies of Inlyta Cancer Drug (1)
Sandoz Inc.’s proposed generic version of Inlyta infringes a patent for the kidney-cancer chemotherapy treatment, Pfizer Inc.
Sandoz, Amneal Get Mixed Ruling in State Drug Price-Fixing Case
Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals Inc. are among a group of generic-drug manufacturers that will face some ...
FiercePharma19h
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Zacks.com on MSN19h
Down -11.04% in 4 Weeks, Here's Why You Should You Buy the Dip in Pfizer (PFE)
Pfizer (PFE) has been on a downward spiral lately with significant selling pressure. After declining 11% over the past four ...
devdiscourse20h
Pharma Updates: Amgen Overcomes Concerns, AstraZeneca Expands, and Pfizer Considers Sale
Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...